|
|
|
|
|
Teisinis statusas
Patento galiojimo terminas pasibaigęs
| (51) | INT.CL. | C07D 231/56 | (2006.01) |
| C07D 403/04 | (2006.01) | ||
| C07D 417/12 | (2006.01) | ||
| C07D 405/06 | (2006.01) | ||
| C07D 401/12 | (2006.01) | ||
| C07D 403/12 | (2006.01) | ||
| C07D 413/12 | (2006.01) | ||
| C07D 401/04 | (2006.01) | ||
| C07D 417/14 | (2006.01) | ||
| C07D 401/14 | (2006.01) | ||
| C07D 405/14 | (2006.01) | ||
| C07D 403/14 | (2006.01) | ||
| C07D 409/06 | (2006.01) | ||
| C07D 409/12 | (2006.01) | ||
| C07D 401/06 | (2006.01) | ||
| C07D 409/14 | (2006.01) | ||
| C07D 471/04 | (2006.01) | ||
| A61K 31/416 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Patento numeris | 1614683 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05015902.9 |
| Europos patento paraiškos padavimo data | 2000-06-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-01-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2007-11-21 |
| (46) | Apibrėžties vertimo paskelbimo data | 2008-02-25 |
| (30) | Numeris | Data | Šalis |
| 142130 P | 1999-07-02 | US |
| (72) |
Collins, Michael Raymond, US
Tempczyk-Russell, Anna Maria, US
Hua, Ye, US
Johnson, Michael David, US
Bender, Steven Lee, US
Kania, Robert Steven, US
Borchardt, Allen J., US
Braganza, John F., US
Cripps, Stephan James, US
Johnson, Theodore Otto Jr., US
Luu, Hiep The, US
Palmer, Cynthia Louise, US
Reich, Siegfried Heinz, US
Teng, Min, US
Thomas, Christine, US
Varney, Michael David, US
Wallace, Michael Brennan, US
|
| (73) |
Agouron Pharmaceuticals, LLC,
10646 Science Center Drive, San Diego, California 92121,
US
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Indazolo junginiai ir farmacinės kompozicijos proteinkinazių slopinimui, ir jų panaudojimo būdai |
| Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2019-06-18 | 20 | 347.00 EUR |